Management of Mental Illness in Patients with Diabetes

Primary Care - Clinics in Office Practice

Volumn 34, Issue 4, 2007, Pages 713-730

  Hilty, Donald M ^a   McCarron, Robert M ^a   Ton, Hendry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; CARBAMAZEPINE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; INSULIN; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; NORTRIPTYLINE; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROATE SEMISODIUM; VENLAFAXINE; ZIPRASIDONE;

AGITATION; ANEMIA; ANXIETY; BIPOLAR DISORDER; CHOLESTEROL BLOOD LEVEL; COGNITION; CONSULTATION; CULTURAL FACTOR; DEPRESSION; DIABETES MELLITUS; EXTRAPYRAMIDAL SYNDROME; HEADACHE; HEALTH; HEALTH BELIEF; HEALTH CARE DELIVERY; HUMAN; HYPERGLYCEMIA; LIVER FUNCTION TEST; MEDICAL DECISION MAKING; MENTAL DISEASE; MOOD; OVARY POLYCYSTIC DISEASE; POLYDIPSIA; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOSIS; RASH; REVIEW; SEDATION; SIDE EFFECT; TARDIVE DYSKINESIA; TREMOR; WEIGHT GAIN;

ANXIETY; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; MENTAL DISORDERS; MOOD DISORDERS; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 36549009517     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2007.08.001     Document Type: Review

References (46)

1. Gavard J.A., Lustman P.J., and Clouse R.E. Prevalence of depression in adults with diabetes: an epidemiological evaluation. Diabetes Care 16 8 (1993) 1167-1178
2. Wells K., Stewart A., Hays R., et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 262 (1989) 914-919
3. Mukherjee S., Decina P., Bocola V., et al. Diabetes mellitus in schizophrenia patients. Compr Psychiatry 37 1 (1996) 68-73
4. Cassidy F., Ahearn E., Carroll B.J., et al. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 156 9 (1999) 1417-1420
5. Dixon L., Weiden P., Delahanty J., et al. Prevalence and correlates of diabetes in national schizophrenic samples. Schizophr Bull 26 4 (2000) 903-912
6. Herman W.H., and Wareham N.J. The diagnosis and classification of diabetes mellitus in nonpregnant adults. Prim Care 26 4 (1999) 755-770
7. Tellez-Zentano J.F., and Cardiel M.H. Risk factors associated with depression in patients with type 2 diabetes mellitus. Arch Med Res 33 1 (2002) 53-60
8. Ikeda K., Aoki H., Saito K., et al. Associations of blood glucose control with self-efficacy and rated anxiety/depression in type II diabetes mellitus patients. Psychol Rep 92 2 (2003) 540-544
9. Chrousos G.P., and Gold P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267 (1992) 1244-1252
10. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43 (1991) 425-473
11. Arborelius L., Owens M.J., Plotsky P.M., et al. The role of corticotrophin-releasing factor in depression and anxiety disorders. J Endocrinol 160 1 (1999) 1-12
12. Stout S.C., Owens M.J., and Memeroff C.B. Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. J Pharmacol Exp Ther 300 3 (2002) 1085-1092
13. Carr V.J., Faehrmann C., Lewin T.J., et al. Determining the effect that consultation-liaison psychiatry in primary care has family physicians' psychiatric knowledge and practice. Psychosomatics 38 3 (1997) 217-229
14. Hilty D.M., Yellowlees P.M., Cobb H.C., et al. Models of telepsychiatric consultation-liaison service to rural primary care. Psychosomatics 47 (2006) 152-157
15. Hilty D.M., Hales R.E., Kunkel E.J.S., et al. Rational selection of antidepressants in primary care. Prim psychiatry 8 8 (2001) 50-57
16. Cooper L.A., Brown C., Vu H.T., et al. Primary care patients' opinions regarding the importance of various aspects of care for depression. Gen Hosp Psychiatry 22 (2000) 163-173
17. Rost K., Nutting P.A., Smith J., et al. Designing and implementing a primary care intervention trial to improve the quality and outcome of care for major depression. Gen Hosp Psychiatry 22 2 (2000) 66-77
18. Lustman P.J., Griffith L.S., Freedland K.E., et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 129 8 (1998) 613-621
19. Katon W., Von Korff M., Lin E.H.B., et al. Distressed high utilizers of medical care: diagnoses and treatment needs. Gen Hosp Psychiatry 12 (1990) 355-362
20. Hilty D.M., Hales R.E., Servis M.E., et al. Algorithms for the diagnosis and management of anxiety disorders in primary care. Prim psychiatry 8 8 (2001) 58-67
21. Lim R.F., Hilty D.M., and Jerant A.F. An algorithm for treating psychotic disorders in primary care. Prim psychiatry 8 8 (2001) 68-74
22. Hilty D.M., Leamon M.L., Lim R.F., et al. Diagnosis and treatment of bipolar disorder in the primary care setting. Prim psychiatry 13 7 (2006) 1192-1198
23. Katon W., Rutter C., Ludman E.J., et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry 58 (2001) 241-247
24. Wells K.B., Unutzer J., Sherbourne C., et al. Cost-effectiveness of practice-initiated quality improvement for depression. JAMA 286 11 (2001) 1325-1330
25. Kessler R.C., McGonagle K.A., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Study. Arch Gen Psychiatry 51 (1994) 8-19
26. Wells K.B., Golding J.M., and Burnam M.A. Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Gen Hosp Psychiatry 11 5 (1989) 320-327
27. Polsky D., Doshi J.A., Marcus S., et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med 165 (2005) 1260-1266
28. Thomas J., Jones G., Scarinci I., et al. A descriptive and comparative study of the prevalence of depressive and anxiety disorders in low-income adults with type 2 diabetes and other chronic illnesses. Diabetes Care 26 (2003) 2311-2317
29. Suarez E.C. C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med 66 (2004) 684-691
30. Ruzickova M., Slaney C., Garnham J., et al. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can J Psychiatry 48 (2003) 458-461
31. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care 27 (2004) 596-601
32. Grundy S.M., Brewer H.B., Cleeman J.I., et al. Definition of Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109 (2004) 433-438
33. McCarron R.M., and Keenan C. Metabolic syndrome. In: Bermudes R.A., Keck P.E., and McElroy S.E. (Eds). A clinical guide for managing metabolic. abnormalities in the psychiatrically ill: what psychiatrists need to know (2007), American Psychiatric Press, Inc., Washington, DC 25-52
34. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
35. McEvoy J.P., Meyer J.M., Goff D.C., et al. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 80 (2005) 19-32
36. Department of Health and Human Services. Mental health: culture, race, and ethnicity: a supplement to mental health: a report of the surgeon general (2001), US Dept of Health and Human Services, Rockville (MD)
37. Thackeray R., Merrill R.M., and Neiger B.L. Disparities in diabetes management practice between racial and ethnic groups in the United States. Diabetes Educ 30 4 (2004) 665-674
38. Chesla C.A., and Chun K.M. Accommodating type 2 diabetes in the Chinese American family. Qual Health Res 15 2 (2005) 240-255
39. Her C., and Mundt M. Risk prevalence for type 2 diabetes mellitus in adult Hmong in Wisconsin: a pilot study. WMJ 104 5 (2006) 70-77
40. Ananth J., Kolli S., Gunatilake S., et al. Atypical antipsychotic drugs, diabetes, and ethnicity. Expert Opin Drug Safety 4 6 (2005) 1111-1124
41. Egede L.E., and Dagogo-Jack S. Epidemiology of type 2 diabetes: focus on ethnic minorities. Med Clin North Am 89 (2005) 949-975
42. Lanting L.C., Joung I.M.A., Mackenbach J.P., et al. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients. Diabetes Care 28 9 (2005) 2280-2288
43. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs. Health Literacy: Rep Council Sci Affairs. JAMA 28 (1999) 552-557
44. Minnesota Diabetes Control Program, Center for Health Promotion, Division of Family Health, Minnesota Department of Health. Voices from the Community: Focus Groups with African American, American Indian, Hispanic, and Hmong People with Diabetes, 1998.
45. Lee E. Overview. The assessment and treatment of Asian American families. In: Lee E. (Ed). Working with Asian Americans (1997), Guilford Press, New York 3-36
46. Ton H., and Lim R.F. The assessment of culturally diverse individuals. In: Lim R.F. (Ed). Cultural psychiatry for clinicians: a handbook for working with diverse patients (2005), American Psychiatric Publishing Inc, Washington, DC 3-28